外部神経調節の世界市場 2020年

• 英文タイトル：Global External Neuromodulation Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201114389 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、外部神経調節の世界市場を調査対象にし、外部神経調節の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（経皮的電気神経刺激、経頭蓋磁気刺激、呼吸器電気刺激）、用途別分析（脊髄刺激、脳深部刺激、仙骨神経刺激、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Medtronic, Inc. (US)、Neuronetics, Inc. (US)、Synapse Biomedical, Inc. (US)、Boston Scientific Corporation (US)、Neuropace, Inc. (US)、St. Jude Medical, Inc. (US)、BioControl Medical (Israel)、Neurosigma, Inc. (US)、Nevro Corporation (US)、Cyberonics, Inc. (US) ・企業別売上、市場シェア ・外部神経調節の地域別市場分析 ・外部神経調節の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・外部神経調節のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・外部神経調節のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・外部神経調節の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・外部神経調節の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・外部神経調節の種類別市場規模2015-2020：経皮的電気神経刺激、経頭蓋磁気刺激、呼吸器電気刺激 ・外部神経調節の用途別市場規模2015-2020：脊髄刺激、脳深部刺激、仙骨神経刺激、その他 ・外部神経調節の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global External Neuromodulation market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The External Neuromodulation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
External Neuromodulation market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, External Neuromodulation market has been segmented into:
Transcutaneous Electrical Nerve Stimulation
Transcranial Magnetic Stimulation
Respiratory Electrical Stimulation

By Application, External Neuromodulation has been segmented into:
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global External Neuromodulation market presented in the report. This section sheds light on the sales growth of different regional and country-level External Neuromodulation markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global External Neuromodulation market.

The report offers in-depth assessment of the growth and other aspects of the External Neuromodulation market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and External Neuromodulation Market Share Analysis
External Neuromodulation competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, External Neuromodulation sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the External Neuromodulation sales, revenue and market share for each player covered in this report.

The major players covered in External Neuromodulation are:
Medtronic, Inc. (US)
Neuronetics, Inc. (US)
Synapse Biomedical, Inc. (US)
Boston Scientific Corporation (US)
Neuropace, Inc. (US)
St. Jude Medical, Inc. (US)
BioControl Medical (Israel)
Neurosigma, Inc. (US)
Nevro Corporation (US)
Cyberonics, Inc. (US)

レポート目次

---

Table of Contents

1 External Neuromodulation Market Overview
1.1 Product Overview and Scope of External Neuromodulation
1.2 Classification of External Neuromodulation by Type
1.2.1 Global External Neuromodulation Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global External Neuromodulation Revenue Market Share by Type in 2019
1.2.3 Transcutaneous Electrical Nerve Stimulation
1.2.4 Transcranial Magnetic Stimulation
1.2.5 Respiratory Electrical Stimulation
1.3 Global External Neuromodulation Market by Application
1.3.1 Overview: Global External Neuromodulation Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Spinal Cord Stimulation
1.3.3 Deep Brain Stimulation
1.3.4 Sacral Nerve Stimulation
1.3.5 Others
1.4 Global External Neuromodulation Market by Regions
1.4.1 Global External Neuromodulation Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of External Neuromodulation (2015-2025)
1.4.3 North America (USA, Canada and Mexico) External Neuromodulation Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) External Neuromodulation Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) External Neuromodulation Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) External Neuromodulation Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) External Neuromodulation Status and Prospect (2015-2025)
2 Company Profiles
2.1 Medtronic, Inc. (US)
2.1.1 Medtronic, Inc. (US) Details
2.1.2 Medtronic, Inc. (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Medtronic, Inc. (US) SWOT Analysis
2.1.4 Medtronic, Inc. (US) Product and Services
2.1.5 Medtronic, Inc. (US) External Neuromodulation Revenue, Gross Margin and Market Share (2018-2019)
2.2 Neuronetics, Inc. (US)
2.2.1 Neuronetics, Inc. (US) Details
2.2.2 Neuronetics, Inc. (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Neuronetics, Inc. (US) SWOT Analysis
2.2.4 Neuronetics, Inc. (US) Product and Services
2.2.5 Neuronetics, Inc. (US) External Neuromodulation Revenue, Gross Margin and Market Share (2018-2019)
2.3 Synapse Biomedical, Inc. (US)
2.3.1 Synapse Biomedical, Inc. (US) Details
2.3.2 Synapse Biomedical, Inc. (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Synapse Biomedical, Inc. (US) SWOT Analysis
2.3.4 Synapse Biomedical, Inc. (US) Product and Services
2.3.5 Synapse Biomedical, Inc. (US) External Neuromodulation Revenue, Gross Margin and Market Share (2018-2019)
2.4 Boston Scientific Corporation (US)
2.4.1 Boston Scientific Corporation (US) Details
2.4.2 Boston Scientific Corporation (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Boston Scientific Corporation (US) SWOT Analysis
2.4.4 Boston Scientific Corporation (US) Product and Services
2.4.5 Boston Scientific Corporation (US) External Neuromodulation Revenue, Gross Margin and Market Share (2018-2019)
2.5 Neuropace, Inc. (US)
2.5.1 Neuropace, Inc. (US) Details
2.5.2 Neuropace, Inc. (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Neuropace, Inc. (US) SWOT Analysis
2.5.4 Neuropace, Inc. (US) Product and Services
2.5.5 Neuropace, Inc. (US) External Neuromodulation Revenue, Gross Margin and Market Share (2018-2019)
2.6 St. Jude Medical, Inc. (US)
2.6.1 St. Jude Medical, Inc. (US) Details
2.6.2 St. Jude Medical, Inc. (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 St. Jude Medical, Inc. (US) SWOT Analysis
2.6.4 St. Jude Medical, Inc. (US) Product and Services
2.6.5 St. Jude Medical, Inc. (US) External Neuromodulation Revenue, Gross Margin and Market Share (2018-2019)
2.7 BioControl Medical (Israel)
2.7.1 BioControl Medical (Israel) Details
2.7.2 BioControl Medical (Israel) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 BioControl Medical (Israel) SWOT Analysis
2.7.4 BioControl Medical (Israel) Product and Services
2.7.5 BioControl Medical (Israel) External Neuromodulation Revenue, Gross Margin and Market Share (2018-2019)
2.8 Neurosigma, Inc. (US)
2.8.1 Neurosigma, Inc. (US) Details
2.8.2 Neurosigma, Inc. (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Neurosigma, Inc. (US) SWOT Analysis
2.8.4 Neurosigma, Inc. (US) Product and Services
2.8.5 Neurosigma, Inc. (US) External Neuromodulation Revenue, Gross Margin and Market Share (2018-2019)
2.9 Nevro Corporation (US)
2.9.1 Nevro Corporation (US) Details
2.9.2 Nevro Corporation (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Nevro Corporation (US) SWOT Analysis
2.9.4 Nevro Corporation (US) Product and Services
2.9.5 Nevro Corporation (US) External Neuromodulation Revenue, Gross Margin and Market Share (2018-2019)
2.10 Cyberonics, Inc. (US)
2.10.1 Cyberonics, Inc. (US) Details
2.10.2 Cyberonics, Inc. (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Cyberonics, Inc. (US) SWOT Analysis
2.10.4 Cyberonics, Inc. (US) Product and Services
2.10.5 Cyberonics, Inc. (US) External Neuromodulation Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global External Neuromodulation Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 External Neuromodulation Players Market Share
3.2.2 Top 10 External Neuromodulation Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global External Neuromodulation Revenue and Market Share by Regions
4.2 North America External Neuromodulation Revenue and Growth Rate (2015-2020)
4.3 Europe External Neuromodulation Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific External Neuromodulation Revenue and Growth Rate (2015-2020)
4.5 South America External Neuromodulation Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa External Neuromodulation Revenue and Growth Rate (2015-2020)
5 North America External Neuromodulation Revenue by Countries
5.1 North America External Neuromodulation Revenue by Countries (2015-2020)
5.2 USA External Neuromodulation Revenue and Growth Rate (2015-2020)
5.3 Canada External Neuromodulation Revenue and Growth Rate (2015-2020)
5.4 Mexico External Neuromodulation Revenue and Growth Rate (2015-2020)
6 Europe External Neuromodulation Revenue by Countries
6.1 Europe External Neuromodulation Revenue by Countries (2015-2020)
6.2 Germany External Neuromodulation Revenue and Growth Rate (2015-2020)
6.3 UK External Neuromodulation Revenue and Growth Rate (2015-2020)
6.4 France External Neuromodulation Revenue and Growth Rate (2015-2020)
6.5 Russia External Neuromodulation Revenue and Growth Rate (2015-2020)
6.6 Italy External Neuromodulation Revenue and Growth Rate (2015-2020)
7 Asia-Pacific External Neuromodulation Revenue by Countries
7.1 Asia-Pacific External Neuromodulation Revenue by Countries (2015-2020)
7.2 China External Neuromodulation Revenue and Growth Rate (2015-2020)
7.3 Japan External Neuromodulation Revenue and Growth Rate (2015-2020)
7.4 Korea External Neuromodulation Revenue and Growth Rate (2015-2020)
7.5 India External Neuromodulation Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia External Neuromodulation Revenue and Growth Rate (2015-2020)
8 South America External Neuromodulation Revenue by Countries
8.1 South America External Neuromodulation Revenue by Countries (2015-2020)
8.2 Brazil External Neuromodulation Revenue and Growth Rate (2015-2020)
8.3 Argentina External Neuromodulation Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue External Neuromodulation by Countries
9.1 Middle East & Africa External Neuromodulation Revenue by Countries (2015-2020)
9.2 Saudi Arabia External Neuromodulation Revenue and Growth Rate (2015-2020)
9.3 UAE External Neuromodulation Revenue and Growth Rate (2015-2020)
9.4 Egypt External Neuromodulation Revenue and Growth Rate (2015-2020)
9.5 South Africa External Neuromodulation Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global External Neuromodulation Revenue and Market Share by Type (2015-2020)
10.2 Global External Neuromodulation Market Forecast by Type (2019-2024)
10.3 Transcutaneous Electrical Nerve Stimulation Revenue Growth Rate (2015-2025)
10.4 Transcranial Magnetic Stimulation Revenue Growth Rate (2015-2025)
10.5 Respiratory Electrical Stimulation Revenue Growth Rate (2015-2025)
11 Global External Neuromodulation Market Segment by Application
11.1 Global External Neuromodulation Revenue Market Share by Application (2015-2020)
11.2 External Neuromodulation Market Forecast by Application (2019-2024)
11.3 Spinal Cord Stimulation Revenue Growth (2015-2020)
11.4 Deep Brain Stimulation Revenue Growth (2015-2020)
11.5 Sacral Nerve Stimulation Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global External Neuromodulation Market Size Forecast (2021-2025)
12.1 Global External Neuromodulation Market Size Forecast (2021-2025)
12.2 Global External Neuromodulation Market Forecast by Regions (2021-2025)
12.3 North America External Neuromodulation Revenue Market Forecast (2021-2025)
12.4 Europe External Neuromodulation Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific External Neuromodulation Revenue Market Forecast (2021-2025)
12.6 South America External Neuromodulation Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa External Neuromodulation Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global External Neuromodulation Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of External Neuromodulation by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global External Neuromodulation Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market External Neuromodulation Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Medtronic, Inc. (US) Corporate Information, Location and Competitors
Table 6. Medtronic, Inc. (US) External Neuromodulation Major Business
Table 7. Medtronic, Inc. (US) External Neuromodulation Total Revenue (USD Million) (2017-2018)
Table 8. Medtronic, Inc. (US) SWOT Analysis
Table 9. Medtronic, Inc. (US) External Neuromodulation Product and Solutions
Table 10. Medtronic, Inc. (US) External Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Neuronetics, Inc. (US) Corporate Information, Location and Competitors
Table 12. Neuronetics, Inc. (US) External Neuromodulation Major Business
Table 13. Neuronetics, Inc. (US) External Neuromodulation Total Revenue (USD Million) (2018-2019)
Table 14. Neuronetics, Inc. (US) SWOT Analysis
Table 15. Neuronetics, Inc. (US) External Neuromodulation Product and Solutions
Table 16. Neuronetics, Inc. (US) External Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Synapse Biomedical, Inc. (US) Corporate Information, Location and Competitors
Table 18. Synapse Biomedical, Inc. (US) External Neuromodulation Major Business
Table 19. Synapse Biomedical, Inc. (US) External Neuromodulation Total Revenue (USD Million) (2017-2018)
Table 20. Synapse Biomedical, Inc. (US) SWOT Analysis
Table 21. Synapse Biomedical, Inc. (US) External Neuromodulation Product and Solutions
Table 22. Synapse Biomedical, Inc. (US) External Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Boston Scientific Corporation (US) Corporate Information, Location and Competitors
Table 24. Boston Scientific Corporation (US) External Neuromodulation Major Business
Table 25. Boston Scientific Corporation (US) External Neuromodulation Total Revenue (USD Million) (2017-2018)
Table 26. Boston Scientific Corporation (US) SWOT Analysis
Table 27. Boston Scientific Corporation (US) External Neuromodulation Product and Solutions
Table 28. Boston Scientific Corporation (US) External Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Neuropace, Inc. (US) Corporate Information, Location and Competitors
Table 30. Neuropace, Inc. (US) External Neuromodulation Major Business
Table 31. Neuropace, Inc. (US) External Neuromodulation Total Revenue (USD Million) (2017-2018)
Table 32. Neuropace, Inc. (US) SWOT Analysis
Table 33. Neuropace, Inc. (US) External Neuromodulation Product and Solutions
Table 34. Neuropace, Inc. (US) External Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. St. Jude Medical, Inc. (US) Corporate Information, Location and Competitors
Table 36. St. Jude Medical, Inc. (US) External Neuromodulation Major Business
Table 37. St. Jude Medical, Inc. (US) External Neuromodulation Total Revenue (USD Million) (2017-2018)
Table 38. St. Jude Medical, Inc. (US) SWOT Analysis
Table 39. St. Jude Medical, Inc. (US) External Neuromodulation Product and Solutions
Table 40. St. Jude Medical, Inc. (US) External Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. BioControl Medical (Israel) Corporate Information, Location and Competitors
Table 42. BioControl Medical (Israel) External Neuromodulation Major Business
Table 43. BioControl Medical (Israel) External Neuromodulation Total Revenue (USD Million) (2017-2018)
Table 44. BioControl Medical (Israel) SWOT Analysis
Table 45. BioControl Medical (Israel) External Neuromodulation Product and Solutions
Table 46. BioControl Medical (Israel) External Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Neurosigma, Inc. (US) Corporate Information, Location and Competitors
Table 48. Neurosigma, Inc. (US) External Neuromodulation Major Business
Table 49. Neurosigma, Inc. (US) External Neuromodulation Total Revenue (USD Million) (2017-2018)
Table 50. Neurosigma, Inc. (US) SWOT Analysis
Table 51. Neurosigma, Inc. (US) External Neuromodulation Product and Solutions
Table 52. Neurosigma, Inc. (US) External Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Nevro Corporation (US) Corporate Information, Location and Competitors
Table 54. Nevro Corporation (US) External Neuromodulation Major Business
Table 55. Nevro Corporation (US) External Neuromodulation Total Revenue (USD Million) (2017-2018)
Table 56. Nevro Corporation (US) SWOT Analysis
Table 57. Nevro Corporation (US) External Neuromodulation Product and Solutions
Table 58. Nevro Corporation (US) External Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Cyberonics, Inc. (US) Corporate Information, Location and Competitors
Table 60. Cyberonics, Inc. (US) External Neuromodulation Major Business
Table 61. Cyberonics, Inc. (US) External Neuromodulation Total Revenue (USD Million) (2017-2018)
Table 62. Cyberonics, Inc. (US) SWOT Analysis
Table 63. Cyberonics, Inc. (US) External Neuromodulation Product and Solutions
Table 64. Cyberonics, Inc. (US) External Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global External Neuromodulation Revenue (Million USD) by Players (2015-2020)
Table 66. Global External Neuromodulation Revenue Share by Players (2015-2020)
Table 67. Global External Neuromodulation Revenue (Million USD) by Regions (2015-2020)
Table 68. Global External Neuromodulation Revenue Market Share by Regions (2015-2020)
Table 69. North America External Neuromodulation Revenue by Countries (2015-2020)
Table 70. North America External Neuromodulation Revenue Market Share by Countries (2015-2020)
Table 71. Europe External Neuromodulation Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific External Neuromodulation Revenue (Million USD) by Countries (2015-2020)
Table 73. South America External Neuromodulation Revenue by Countries (2015-2020)
Table 74. South America External Neuromodulation Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa External Neuromodulation Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa External Neuromodulation Revenue Market Share by Countries (2015-2020)
Table 77. Global External Neuromodulation Revenue (Million USD) by Type (2015-2020)
Table 78. Global External Neuromodulation Revenue Share by Type (2015-2020)
Table 79. Global External Neuromodulation Revenue Forecast by Type (2021-2025)
Table 80. Global External Neuromodulation Revenue by Application (2015-2020)
Table 81. Global External Neuromodulation Revenue Share by Application (2015-2020)
Table 82. Global External Neuromodulation Revenue Forecast by Application (2021-2025)
Table 83. Global External Neuromodulation Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. External Neuromodulation Picture
Figure 2. Global External Neuromodulation Revenue Market Share by Type in 2019
Figure 3. Transcutaneous Electrical Nerve Stimulation Picture
Figure 4. Transcranial Magnetic Stimulation Picture
Figure 5. Respiratory Electrical Stimulation Picture
Figure 6. External Neuromodulation Revenue Market Share by Application in 2019
Figure 7. Spinal Cord Stimulation Picture
Figure 8. Deep Brain Stimulation Picture
Figure 9. Sacral Nerve Stimulation Picture
Figure 10. Others Picture
Figure 11. Global External Neuromodulation Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America External Neuromodulation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe External Neuromodulation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific External Neuromodulation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America External Neuromodulation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa External Neuromodulation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global External Neuromodulation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global External Neuromodulation Revenue Share by Players in 2019
Figure 19. Global Top 5 Players External Neuromodulation Revenue Market Share in 2019
Figure 20. Global Top 10 Players External Neuromodulation Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global External Neuromodulation Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global External Neuromodulation Revenue Market Share by Regions (2015-2020)
Figure 24. Global External Neuromodulation Revenue Market Share by Regions in 2018
Figure 25. North America External Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 26. Europe External Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific External Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 28. South America External Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa External Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 30. North America External Neuromodulation Revenue Market Share by Countries (2015-2020)
Figure 31. North America External Neuromodulation Revenue Market Share by Countries in 2019
Figure 32. USA External Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 33. Canada External Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 34. Mexico External Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 35. Europe External Neuromodulation Revenue Market Share by Countries (2015-2020)
Figure 36. Europe External Neuromodulation Revenue Market Share by Countries in 2019
Figure 37. Germany External Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 38. UK External Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 39. France External Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 40. Russia External Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 41. Italy External Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific External Neuromodulation Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific External Neuromodulation Revenue Market Share by Countries in 2019
Figure 44. China External Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 45. Japan External Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 46. Korea External Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 47. India External Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia External Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 49. South America External Neuromodulation Revenue Market Share by Countries (2015-2020)
Figure 50. South America External Neuromodulation Revenue Market Share by Countries in 2019
Figure 51. Brazil External Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 52. Argentina External Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa External Neuromodulation Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa External Neuromodulation Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia External Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 56. UAE External Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 57. Egypt External Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 58. South Africa External Neuromodulation Revenue and Growth Rate (2015-2020)
Figure 59. Global External Neuromodulation Revenue Share by Type (2015-2020)
Figure 60. Global External Neuromodulation Revenue Share by Type in 2019
Figure 61. Global External Neuromodulation Market Share Forecast by Type (2021-2025)
Figure 62. Global Transcutaneous Electrical Nerve Stimulation Revenue Growth Rate (2015-2020)
Figure 63. Global Transcranial Magnetic Stimulation Revenue Growth Rate (2015-2020)
Figure 64. Global Respiratory Electrical Stimulation Revenue Growth Rate (2015-2020)
Figure 65. Global External Neuromodulation Revenue Share by Application (2015-2020)
Figure 66. Global External Neuromodulation Revenue Share by Application in 2019
Figure 67. Global External Neuromodulation Market Share Forecast by Application (2021-2025)
Figure 68. Global Spinal Cord Stimulation Revenue Growth Rate (2015-2020)
Figure 69. Global Deep Brain Stimulation Revenue Growth Rate (2015-2020)
Figure 70. Global Sacral Nerve Stimulation Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global External Neuromodulation Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global External Neuromodulation Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global External Neuromodulation Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America External Neuromodulation Revenue Market Forecast (2021-2025)
Figure 76. Europe External Neuromodulation Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific External Neuromodulation Revenue Market Forecast (2021-2025)
Figure 78. South America External Neuromodulation Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa External Neuromodulation Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---